Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error and navigation, hiding the study record details that were previously listed (e.g., title, conditions, inclusion/exclusion criteria, locations, and contacts).SummaryDifference19%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays the latest system revision tag (v3.6.6) replacing the previous v3.6.5. This indicates a software update and does not alter the study details, eligibility criteria, or results on the page.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small internal update to the page or CMS. No user-visible content changes are expected.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s revision label was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/display. No study content appears to be changed.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a new minor update to the record. This maintenance update does not alter study details or eligibility information.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a new build of the study record.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.